Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context

The immunosuppressants cyclosporin A and FK506 (tacrolimus) can block the phosphatase calcineurin, thereby inhibiting gene transcription directed by the cyclic AMP (cAMP)- and calcium-responsive transcription factor, cAMP response element (CRE)-binding protein, and its binding site, CRE, in various...

Full description

Saved in:
Bibliographic Details
Main Authors: Siemann, Gero (Author) , Blume, Roland (Author) , Grapentin, Daniela (Author) , Oetjen, Elke (Author) , Schwaninger, Markus (Author) , Knepel, Willhart (Author)
Format: Article (Journal)
Language:English
Published: June 1, 1999
In: Molecular pharmacology
Year: 1999, Volume: 55, Issue: 6, Pages: 1094-1100
ISSN:1521-0111
DOI:10.1124/mol.55.6.1094
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1124/mol.55.6.1094
Verlag, lizenzpflichtig, Volltext: https://molpharm.aspetjournals.org/content/55/6/1094
Get full text
Author Notes:Gero Siemann, Roland Blume, Daniela Grapentin, Elke Oetjen, Markus Schwaninger, and Willhart Knepel

MARC

LEADER 00000caa a2200000 c 4500
001 1753050502
003 DE-627
005 20230427070853.0
007 cr uuu---uuuuu
008 210401s1999 xx |||||o 00| ||eng c
024 7 |a 10.1124/mol.55.6.1094  |2 doi 
035 |a (DE-627)1753050502 
035 |a (DE-599)KXP1753050502 
035 |a (OCoLC)1341402147 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Siemann, Gero  |e VerfasserIn  |0 (DE-588)1230563199  |0 (DE-627)1753054168  |4 aut 
245 1 0 |a Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context  |c Gero Siemann, Roland Blume, Daniela Grapentin, Elke Oetjen, Markus Schwaninger, and Willhart Knepel 
264 1 |c June 1, 1999 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.04.2021 
520 |a The immunosuppressants cyclosporin A and FK506 (tacrolimus) can block the phosphatase calcineurin, thereby inhibiting gene transcription directed by the cyclic AMP (cAMP)- and calcium-responsive transcription factor, cAMP response element (CRE)-binding protein, and its binding site, CRE, in various cell lines. This action is a novel molecular mechanism of cyclosporin A and FK506 action. Because inhibition of CREB/CRE-directed transcription by cyclosporin A and FK506 has previously been observed by using synthetic minienhancers, reporter fusion genes were constructed to examine the effect of cyclosporin A and FK506 on the transcriptional activity of CRE-containing natural promoters. In transient transfection experiments, cyclosporin A and FK506 inhibited the transcriptional activation by cAMP and the membrane depolarization of three CRE-containing promoters. However, cyclosporin A and FK506 failed to inhibit the activation by cAMP of another promoter, the rat insulin I gene promoter. The lack of cyclosporin A/FK506 sensitivity is not intrinsic to the insulin CRE because cyclosporin A and FK506 inhibited the activation by cAMP of the insulin CRE when isolated and used as a synthetic minienhancer. Rather, cyclosporin A/FK506 resistance may be conferred by specific promoter interactions because a mutational analysis of the insulin promoter revealed that inside this promoter, CRE activity depends on an adjacent control element. These data show that cyclosporin A and FK506 can inhibit CRE activity when the CRE resides in its natural promoter. However, the cyclosporin A/FK506 sensitivity depends on the specific promoter context. The results suggest that cyclosporin A and FK506 may alter target tissue function through the regulation of a subset of CRE-containing genes. 
700 1 |a Blume, Roland  |e VerfasserIn  |4 aut 
700 1 |a Grapentin, Daniela  |e VerfasserIn  |4 aut 
700 1 |a Oetjen, Elke  |e VerfasserIn  |4 aut 
700 1 |a Schwaninger, Markus  |e VerfasserIn  |0 (DE-588)1028374909  |0 (DE-627)730623939  |0 (DE-576)375910174  |4 aut 
700 1 |a Knepel, Willhart  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular pharmacology  |d Bethesda, Md. : ASPET, 1965  |g 55(1999), 6, Seite 1094-1100  |h Online-Ressource  |w (DE-627)269534695  |w (DE-600)1475030-2  |w (DE-576)077884795  |x 1521-0111  |7 nnas  |a Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context 
773 1 8 |g volume:55  |g year:1999  |g number:6  |g pages:1094-1100  |g extent:7  |a Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context 
856 4 0 |u https://doi.org/10.1124/mol.55.6.1094  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://molpharm.aspetjournals.org/content/55/6/1094  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210401 
993 |a Article 
994 |a 1999 
998 |g 1028374909  |a Schwaninger, Markus  |m 1028374909:Schwaninger, Markus  |d 910000  |d 911100  |e 910000PS1028374909  |e 911100PS1028374909  |k 0/910000/  |k 1/910000/911100/  |p 5 
999 |a KXP-PPN1753050502  |e 3901212299 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1753050502","language":["eng"],"name":{"displayForm":["Gero Siemann, Roland Blume, Daniela Grapentin, Elke Oetjen, Markus Schwaninger, and Willhart Knepel"]},"relHost":[{"part":{"volume":"55","year":"1999","extent":"7","issue":"6","pages":"1094-1100","text":"55(1999), 6, Seite 1094-1100"},"language":["eng"],"name":{"displayForm":["American Society for Pharmacology and Experimental Therapeutics"]},"origin":[{"dateIssuedDisp":"1965-","publisher":"ASPET","publisherPlace":"Bethesda, Md.","dateIssuedKey":"1965"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society for Pharmacology and Experimental Therapeutics"}],"titleAlt":[{"title":"Molecular pharmacology online"}],"pubHistory":["1.1965 -"],"title":[{"title":"Molecular pharmacology","title_sort":"Molecular pharmacology"}],"note":["Gesehen am 14.01.2025"],"id":{"zdb":["1475030-2"],"eki":["269534695"],"issn":["1521-0111"]},"recId":"269534695","disp":"Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter contextMolecular pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1753050502"],"doi":["10.1124/mol.55.6.1094"]},"note":["Gesehen am 01.04.2021"],"title":[{"title":"Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context","title_sort":"Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context"}],"person":[{"family":"Siemann","display":"Siemann, Gero","given":"Gero","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Blume","display":"Blume, Roland","roleDisplay":"VerfasserIn","given":"Roland","role":"aut"},{"given":"Daniela","roleDisplay":"VerfasserIn","role":"aut","family":"Grapentin","display":"Grapentin, Daniela"},{"family":"Oetjen","display":"Oetjen, Elke","given":"Elke","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Schwaninger","display":"Schwaninger, Markus","given":"Markus","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Knepel, Willhart","family":"Knepel","roleDisplay":"VerfasserIn","given":"Willhart","role":"aut"}],"physDesc":[{"extent":"7 S."}],"origin":[{"dateIssuedDisp":"June 1, 1999","dateIssuedKey":"1999"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a SIEMANNGERINHIBITION1199